litlas
ログインアカウント作成

Rachel Schiff

1998–2025 年に発表

120
論文数
22,519
被引用数
84
h 指数
115
i10 指数

被引用数

Rachel Schiff の年別被引用数1970 年: 被引用 1 件1993 年: 被引用 1 件1996 年: 被引用 1 件1998 年: 被引用 8 件1999 年: 被引用 33 件2000 年: 被引用 53 件2001 年: 被引用 41 件2002 年: 被引用 56 件2003 年: 被引用 68 件2004 年: 被引用 77 件2005 年: 被引用 152 件2006 年: 被引用 123 件2007 年: 被引用 139 件2008 年: 被引用 196 件2009 年: 被引用 132 件2010 年: 被引用 170 件2011 年: 被引用 254 件2012 年: 被引用 212 件2013 年: 被引用 219 件2014 年: 被引用 270 件2015 年: 被引用 263 件2016 年: 被引用 232 件2017 年: 被引用 235 件2018 年: 被引用 257 件2019 年: 被引用 754 件2020 年: 被引用 824 件2021 年: 被引用 875 件2022 年: 被引用 696 件2023 年: 被引用 555 件2024 年: 被引用 661 件2025 年: 被引用 368 件2026 年: 被引用 12 件1971〜1992 年は被引用が無いため表示していません1994〜1995 年は被引用が無いため表示していません1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,972 件、この内訳の 31.3%中国: 引用元論文 1,139 件、この内訳の 12%イギリス: 引用元論文 569 件、この内訳の 6%イタリア: 引用元論文 506 件、この内訳の 5.3%ドイツ: 引用元論文 324 件、この内訳の 3.4%スペイン: 引用元論文 294 件、この内訳の 3.1%フランス: 引用元論文 286 件、この内訳の 3%カナダ: 引用元論文 278 件、この内訳の 2.9%オーストラリア: 引用元論文 224 件、この内訳の 2.4%日本: 引用元論文 219 件、この内訳の 2.3%オランダ: 引用元論文 214 件、この内訳の 2.3%インド: 引用元論文 198 件、この内訳の 2.1%
0%31.3%その他 23.9%

機関

分野

  • Biochemistry, Genetics and Molecular Biology53.2%
  • Medicine37.8%
  • Engineering1.9%
  • Immunology and Microbiology1.8%
  • Materials Science1.2%
  • Computer Science1%
  • その他3.1%

トピック

  • HER2/EGFR in Cancer Research6.4%
  • Estrogen and related hormone effects6.3%
  • Advanced Breast Cancer Therapies4.3%
  • Breast Cancer Treatment Studies4.1%
  • Cancer Cells and Metastasis3.7%
  • Cancer Genomics and Diagnostics2.4%
  • その他72.8%

共著者

全論文

検索で開く
  1. ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer

    著者: Rinath Jeselsohn, Gilles Buchwalter, Carmine De Angelis, Myles Brown, Rachel Schiff - Nature Reviews Clinical Oncology 2015 被引用: 685

  2. HER2: Biology, Detection, and Clinical Implications

    著者: Carolina Gutiérrez, Rachel Schiff - Archives of Pathology & Laboratory Medicine 2011 被引用: 633

  3. Mechanisms of Endocrine Resistance in Breast Cancer

    著者: C. Kent Osborne, Rachel Schiff - Annual Review of Medicine 2010 被引用: 1,173

  4. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo

    著者: Kristen L. Meerbrey, Guang Hu, Jessica D. Kessler, Kevin Roarty, Mamie Z. Li, Justin E. Fang, Jason I. Herschkowitz, Anna E. Burrows, Alberto Ciccia, Tingting Sun, Earlene M. Schmitt, Ronald J. Bernardi, Xiaoyong Fu, Christopher S. Bland, Thomas A. Cooper, Rachel Schiff, Jeffrey M. Rosen, Thomas F. Westbrook, Stephen J. Elledge - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 被引用: 709

  5. Towards personalized treatment for early stage HER2-positive breast cancer

    著者: Kristina Goutsouliak, Jamunarani Veeraraghavan, Vidyalakshmi Sethunath, Carmine De Angelis, C. Kent Osborne, Mothaffar F. Rimawi, Rachel Schiff - Nature Reviews Clinical Oncology 2019 被引用: 296

  6. MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis

    著者: Atsushi Terunuma, Nagireddy Putluri, Prachi Mishra, Ewy A. Mathé, Tiffany H. Dorsey, Ming Yi, Tiffany A. Wallace, Haleem J. Issaq, Ming Zhou, J. Keith Killian, Holly Stevenson, Edward D. Karoly, King Hong Chan, Susmita Samanta, DaRue A. Prieto, Tiffany Hsu, Sarah J. Kurley, Vasanta Putluri, Rajni Sonavane, Daniel C. Edelman, Jacob Wulff, Adrienne M. Starks, Yinmeng Yang, Rick A. Kittles, Harry G. Yfantis, Dong Hoon Lee, Olga B. Ioffe, Rachel Schiff, Robert M. Stephens, Paul S. Meltzer, Timothy D. Veenstra, Thomas F. Westbrook, Arun Sreekumar, Stefan Ambs - Journal of Clinical Investigation 2013 被引用: 470

  7. HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis

    著者: Francesco Schettini, Tomás Pascual, Benedetta Conte, Núria Chic, Fara Brasó‐Maristany, Patricia Galván, Olga Martínez‐Sáez, Bárbara Adamo, María Vidal, Montserrat Muñoz-Mateu, Aranzazu Fernández-Martínez, Carla Rognoni, Gaia Griguolo, Valentina Guarneri, PierFranco Conte, Mariavittoria Locci, Jan C. Brase, Blanca González‐Farré, Patricia Villagrasa, Sabino De Placido, Rachel Schiff, Jamunarani Veeraraghavan, Mothaffar F. Rimawi, C. Kent Osborne, Sònia Pernas, Charles M. Perou, Lisa A. Carey, Aleix Prat - Cancer Treatment Reviews 2020 被引用: 185

  8. The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells

    著者: Igor Bado, Weijie Zhang, Jingyuan Hu, Zhan Xu, Hai Wang, Poonam Sarkar, Lucian Li, Ying‐Wooi Wan, Jun Liu, William Wu, Hin Ching Lo, Ik Sun Kim, Swarnima Singh, Mahnaz Janghorban, Aaron M. Muscarella, Amit Goldstein, Purba Singh, Hyun-Hwan Jeong, Chaozhong Liu, Rachel Schiff, Shixia Huang, Matthew J. Ellis, M. Waleed Gaber, Zbigniew Gugala, Zhandong Liu, Xiang H.-F. Zhang - Developmental Cell 2021 被引用: 119

  9. Targeting HER2 for the Treatment of Breast Cancer

    著者: Mothaffar F. Rimawi, Rachel Schiff, C. Kent Osborne - Annual Review of Medicine 2015 被引用: 270

  10. Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance

    著者: Mingjun Bi, Zhao Zhang, Yi‐Zhou Jiang, Pengya Xue, Hu Wang, Zhao Lai, Xiaoyong Fu, Carmine De Angelis, Yue Gong, Zhen Gao, Jianhua Ruan, Victor X. Jin, Elisabetta Marangoni, Élodie Montaudon, Christopher K. Glass, Wei Li, Tim H.‐M. Huang, Zhi‐Ming Shao, Rachel Schiff, Lizhen Chen, Zhijie Liu - Nature Cell Biology 2020 被引用: 139

  11. Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

    著者: Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan, Sarmistha Nanda, Lanfang Qin, Vidyalakshmi Sethunath, Tao Wang, Susan G. Hilsenbeck, Matteo Benelli, Ilenia Migliaccio, Cristina Guarducci, Luca Malorni, Lacey M. Litchfield, Jiangang Liu, Joshua Donaldson, Pier Selenica, David N. Brown, Britta Weigelt, Jorge S. Reis‐Filho, Ben Ho Park, Sara A. Hurvitz, Dennis J. Slamon, Mothaffar F. Rimawi, Valerie M. Jansen, Rinath Jeselsohn, C. Kent Osborne, Rachel Schiff - Clinical Cancer Research 2021 被引用: 94

  12. Bidirectional Crosstalk between the Estrogen Receptor and Human Epidermal Growth Factor Receptor 2 Signaling Pathways in Breast Cancer: Molecular Basis and Clinical Implications

    著者: Mario Giuliano, Meghana V. Trivedi, Rachel Schiff - Breast Care 2013 被引用: 200

  13. FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer

    著者: Xiaoyong Fu, Resel Pereira, Carmine De Angelis, Jamunarani Veeraraghavan, Sarmistha Nanda, Lanfang Qin, Maria Letizia Cataldo, Vidyalakshmi Sethunath, Sepideh Mehravaran, Carolina Gutiérrez, Gary C. Chamness, Qin Feng, Bert W. O’Malley, Pier Selenica, Britta Weigelt, Jorge S. Reis‐Filho, Ofir Cohen, Nikhil Wagle, Agostina Nardone, Rinath Jeselsohn, Myles Brown, Mothaffar F. Rimawi, C. Kent Osborne, Rachel Schiff - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 被引用: 171

  14. A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

    著者: Jenny C. Chang, Qing Lai, Pavel Zuloaga, Amber M. Froehlich, Edward S. Chen, Jian Huang, Mario Giuliano, Sofie Claerhout, Gordon B. Mills, Chad A. Shaw, Suzanne A.W. Fuqua, Michael T. Lewis, Charles M. Perou, Mothaffar F. Rimawi, Alejandro Contreras, Carolina Gutiérrez, Anna Tsimelzon, Xiaomei Zhang, Sufeng Mao, Susan G. Hilsenbeck, M. F. Wu, Anne C. Pavlick, Helen Wong, Aleix Prat, Lisa Wiechmann, Ivana Petrović, Lacey E. Dobrolecki, Rachel Schiff, Melissa D. Landis - Cancer Research 2013 被引用: 485

  15. HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

    著者: Aleix Prat, Tomás Pascual, Carmine De Angelis, Carolina Gutiérrez, Antonio Llombart‐Cussac, Tao Wang, Javier Cortés, Brent N. Rexer, Laia Paré, Andres Forero, Antonio C. Wolff, Serafín Morales, Bárbara Adamo, Fara Brasó‐Maristany, María Vidal, Jamunarani Veeraraghavan, Ian E. Krop, Patricia Galván, Anne C. Pavlick, Begoña Bermejo, Miguel Izquierdo, Vanessa Rodrik-Outmezguine, Jorge S. Reis‐Filho, Susan G. Hilsenbeck, Mafalda Oliveira, Maria Vittoria Dieci, Gaia Griguolo, Roberta Fasani, Paolo Nucíforo, Joel S. Parker, PierFranco Conte, Rachel Schiff, Valentina Guarneri, C. Kent Osborne, Mothaffar F. Rimawi - JNCI Journal of the National Cancer Institute 2019 被引用: 169

  16. Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer

    著者: Cristina Guarducci, Martina Bonechi, Matteo Benelli, Chiara Biagioni, Giulia Boccalini, Dario Romagnoli, Roberto Verardo, Rachel Schiff, C. Kent Osborne, Carmine De Angelis, Angelo Di Leo, Luca Malorni, Ilenia Migliaccio - npj Breast Cancer 2018 被引用: 135

  17. Microscaled proteogenomic methods for precision oncology

    著者: Shankha Satpathy, Eric J. Jaehnig, Karsten Krug, Beom‐Jun Kim, Alexander B. Saltzman, Doug W. Chan, Kimberly R. Holloway, Meenakshi Anurag, Chen Huang, Purba Singh, Ari Gao, Noel Namai, Yongchao Dou, Bo Wen, Suhas Vasaikar, David G. Mutch, Mark A. Watson, X. Cynthia, Foluso O. Ademuyiwa, Mothaffar F. Rimawi, Rachel Schiff, Jeremy Hoog, Samuel A. Jacobs, Anna Malovannaya, Terry Hyslop, Karl R. Clauser, D.R. Mani, Charles M. Perou, George Miles, Bing Zhang, Michael A. Gillette, Steven A. Carr, Matthew J. Ellis - Nature Communications 2020 被引用: 122

  18. Mechanisms of Tamoxifen Resistance: Increased Estrogen Receptor-HER2/neu Cross-Talk in ER/HER2-Positive Breast Cancer

    著者: Jianzhong Shou, Suleiman Massarweh, C. K. Osborne, A. E. Wakeling, Simak Ali, Helen A. Weiss, Rachel Schiff - JNCI Journal of the National Cancer Institute 2004 被引用: 1,169

  19. Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function

    著者: Suleiman Massarweh, C. Kent Osborne, Chad J. Creighton, Lanfang Qin, Anna Tsimelzon, Shixia Huang, Heidi L. Weiss, Mothaffar F. Rimawi, Rachel Schiff - Cancer Research 2008 被引用: 494

  20. Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers - role of estrogen receptor and HER2 reactivation

    著者: Yen-Chao Wang, Gladys Morrison, Ryan Gillihan, Jun Guo, Robin Ward, Xiaoyong Fu, Maria F. Botero, Nuala Healy, Susan G. Hilsenbeck, Gail D. Lewis Phillips, Gary C. Chamness, Mothaffar F. Rimawi, C. Kent Osborne, Rachel Schiff - Breast Cancer Research 2011 被引用: 283

  21. A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis

    著者: Jessica D. Kessler, Kristopher T. Kahle, Tingting Sun, Kristen L. Meerbrey, Michael R. Schlabach, Earlene M. Schmitt, Samuel O. Skinner, Qikai Xu, Mamie Z. Li, Zachary C. Hartman, Mitchell Rao, Peng Yu, Rocío Domínguez-Vidaña, Anthony C. Liang, Nicole L. Solimini, Ronald J. Bernardi, Bing Yu, Tiffany Hsu, Ido Golding, Ji Luo, C. Kent Osborne, Chad J. Creighton, Susan G. Hilsenbeck, Rachel Schiff, Chad A. Shaw, Stephen J. Elledge, Thomas F. Westbrook - Science 2011 被引用: 440

  22. Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer

    著者: Xiang H.-F. Zhang, Mario Giuliano, Meghana V. Trivedi, Rachel Schiff, C. Kent Osborne - Clinical Cancer Research 2013 被引用: 273

  23. Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2–ERα–GREB1 Transcriptional Axis

    著者: Yanming Wu, Zhao Zhang, Mauro E. Cenciarini, Cecilia J. Proietti, Matías Amasino, Tao Hong, Mei Yang, Yiji Liao, Huai-Chin Chiang, Virginia Kaklamani, Rinath Jeselsohn, Ratna K. Vadlamudi, Tim H.‐M. Huang, Rong Li, Carmine De Angelis, Xiaoyong Fu, Patricia V. Elizalde, Rachel Schiff, Myles Brown, Kexin Xu - Cancer Research 2017 被引用: 113

  24. Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

    著者: Cristina Guarducci, Agostina Nardone, Douglas Russo, Zsuzsanna Nagy, Capucine Héraud, Albert Grinshpun, Qi Zhang, Allegra Freelander, Matthew Leventhal, Avery Feit, Gabriella Cohen, Ariel Feiglin, Weihan Liu, Francisco Hermida‐Prado, Nikolas Kesten, Wen Ma, Carmine De Angelis, Antonio Morlando, Madison O'Donnell, Sergey Naumenko, Shixia Huang, Quang‐Dé Nguyen, Ying Huang, Luca Malorni, Johann S. Bergholz, Jean J. Zhao, Ernest Fraenkel, Elgene Lim, Rachel Schiff, Geoffrey I. Shapiro, Rinath Jeselsohn - Clinical Cancer Research 2024 被引用: 35